Home › Gallbladder Cancer › New York › New York City
Gallbladder Cancer clinical trials in New York City, NY
4 studies for Gallbladder Cancer are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecruitingPhase 1/2
- Columbia University Medical Center, New York
- Memorial Sloan Kettering, New York
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
RecruitingPhase 3
- Memorial Sloan Kettering Cancer Center (Site 108), New York
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
RecruitingPhase 3
- Research Site, New York
- Research Site, New York
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
RecruitingPhase 3
- Memorial Sloan Kettering Cancer Centers, New York
About Gallbladder Cancer
Gallbladder cancer is difficult to diagnose because there are no symptoms in its early stages. Read about tests, treatment options and prognosis.
More about Gallbladder Cancer on MedlinePlus
Gallbladder Cancer trials in other cities
- Nashville, TN4 studies
- Baldwin Park, CA4 studies
- Cleveland, OH4 studies
- Dallas, TX3 studies
- Philadelphia, PA3 studies
- Birmingham, AL3 studies
- Louisville, KY3 studies
- Portland, OR3 studies
- Los Angeles, CA3 studies
- Houston, TX3 studies
- Oklahoma City, OK3 studies
- Pittsburgh, PA3 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.